Radar on Medicare Advantage
-
News Briefs
Anthem Blue Cross and Blue Shield and Centene Corp.’s Managed Health Services (MHS) secured new four-year contracts to serve the Indiana state Medicaid program, Hoosier Care Connect. The new pacts, which start in April 2021, include the option for two one-year renewals, according to a press release from Centene. Anthem currently serves more than 500,000 Medicaid members across the state, while MHS serves more than 330,000 enrollees. View the releases at https://bwnews.pr/32hnW84 and https://prn.to/2YxNbSS.
After successful ballot initiatives in Missouri and Oklahoma, South Dakota voters may decide the fate of Medicaid expansion in that state. South Dakota Attorney General Jason Ravnsborg (R) posted explanations for two petitions that will circulate in an effort to gain enough signatures for a ballot initiative in 2022. One of the measures would create a constitutional amendment (similar to Oklahoma’s approach) and the other would direct the state legislature to expand Medicaid. Expansion advocates have until November 2021 to collect enough signatures. Visit https://bit.ly/2EXnd42.
-
MA, Cost, PACE, Demo and Prescription Drug Plan Contract Enrollment Report (August 2020)
Enrollment in Medicare Advantage plans reached 25.2 million enrollees as of the Aug. 1, 2020, payment date, according to new monthly summary data from CMS. The payment reflects enrollments accepted through July 10. In an Aug. 19 research note from Credit Suisse, securities analyst A.J. Rice observed that year-to-date (YTD) enrollment growth is 8%, beating the pace of the previous two years, which was 6.4% and 6.6%, respectively. “The five major MCOs (including CVS), which account for roughly 61.7% of total MA enrollments, have cumulatively grown 10.0% YTD vs. 4.9% YTD growth for the remaining MA plans,” he noted. -
Proposed MCIT Rule Aims to Speed Senior Access to Breakthrough Devices
Carrying out another directive from President Trump’s Medicare-focused executive order issued last fall (RMA 10/17/19, p. 3), CMS on Aug. 31 released a proposed rule that aims to fast-track Medicare coverage of certain innovative FDA therapies once they are approved. Although the rule applies to Medicare fee for service, it has implications for Medicare Advantage organizations that are required to cover Medicare Parts A and B approved services.
According to a CMS fact sheet on the rule, CMS is proposing a new Medicare coverage pathway, Medicare Coverage of Innovative Technology (MCIT), for medical devices that are granted breakthrough designation by the FDA. The MCIT proposal would allow for national Medicare coverage on the same day as a breakthrough device receives FDA approval. CMS proposes a coverage duration of four years, which it suggests will “encourage manufacturers to voluntarily develop evidence to show these treatments improve the health of Medicare patients.”
-
OIG Urges CMS to Tweak Encounter Data System to Avoid Fraud
In its latest review of the Encounter Data System (EDS) that is used largely to determine Medicare Advantage plan payments, the HHS Office of Inspector General (OIG) urged CMS for the second time to incorporate National Provider Identifiers (NPIs) into its collection of data from MA organizations. Despite their potential to improve program integrity in certain fraud-prone areas, NPIs for ordering providers are still not required in encounter data submissions and continue to be “largely missing” from records submitted by MAOs, observed the new OIG report.
CMS in 2012 began collecting encounter data from MAOs and, with the goal of eventually replacing the legacy Risk Adjustment Payment System, in 2016 began using it to determine risk-adjusted payments to MAOs. But the agency has always maintained that it could be used for program integrity and research purposes and in 2018 began making MA encounter data available to researchers. Last year, the Medicare Payment Advisory Commission suggested that encounter data also be used to determine star quality ratings at a local level (RMA 3/21/19, p. 3).
-
Plans, Providers Pursue Lasting Change to MA Telehealth Policy
Before a pandemic forced the rapid adoption of telehealth in the U.S., the Trump administration had already implemented or was taking steps to support the use of telehealth in the Medicare Advantage program. But one remaining barrier for plan adoption of telehealth was the inability to collect diagnosis codes for risk adjustment purposes. CMS temporarily addressed this issue during the pandemic, but as providers anticipate telehealth to play a more permanent role in health care delivery, they are joining with plans to advocate for a permanent shift in MA telehealth policy.
CMS in an April 10 memo to plans stated that MA “organizations and other organizations that submit diagnoses for risk adjusted payment are able to submit diagnoses for risk adjustment that are from telehealth visits when those visits meet all criteria for risk adjustment eligibility, which include being from an allowable inpatient, outpatient, or professional service, and from a face-to-face encounter” (RMA 4/16/20, p. 3). The document said little else, other than specifying that such diagnoses would count only when the services are provided using an interactive audio and video telecommunications system that allows for “real-time interactive communication.”
The Latest
Complimentary Publications
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters